Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases
Clinical trial NCT07362758 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07362758
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-01-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.